| Literature DB >> 35739980 |
Zhenlin Fan1, Qi Yan1, Jian Song2, Jingyan Wei1,3.
Abstract
Plasma glutathione peroxidase (GPx3) belongs to the GPx superfamily, and it is the only known secreted selenocysteine (Sec)-containing GPx in humans. It exists as a glycosylated homotetramer and catalyzes the reduction of hydrogen peroxide and lipid peroxides, depending on the Sec in its active center. In this study, a previously reported chimeric tRNAUTuT6 was used for the incorporation of Sec at the UAG amber codon, and the mature form of human GPx3 (hGPx3) without the signal peptide was expressed in amber-less E. coli C321.ΔA.exp. Reactive Sec-hGPx3, able to reduce H2O2 and tert-butyl hydroperoxide (t-BuOOH), was produced with high purity and yield. Study of the quaternary structure suggested that the recombinant Sec-hGPx3 contained an intra-molecular disulfide bridge but failed to form tetramer. Mutational and structural analysis of the mutants with three Cys residues, individually or jointly replaced with Ser, indicated that the formation of intra-molecular disulfide bridges involved structure conformational changes. The secondary structure containing Cys77 and Cys132 was flexible and could form a disulfide bond, or form a sulfhydryl-selenyl bond with Sec49 in relative mutants. Mutation of Cys8 and Cys132 to Sec8 and Sec132 could fix the oligomerization loop through the formation of diselenide bond, which, in turn, facilitated tetramer formation and noticeably improved the GPx activity. This research provides an important foundation for the further catalysis and functional study of hGPx3.Entities:
Keywords: diselenide; enzyme kinetics; glutathione peroxidase; protein conformation; selenoprotein
Year: 2022 PMID: 35739980 PMCID: PMC9220127 DOI: 10.3390/antiox11061083
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Plasmids and E. coli strains used in this study.
| Strain/Plasmid | Description | Source |
|---|---|---|
| Strains | ||
| DH5α | Conventional host for plasmid propagation | Invitrogen |
| C321.ΔA.exp | Recoded E.coli MG1655 strain with all of its UAG codon depleted and UAG termination function removed | Marc Lajoie et al. [ |
| Plasmids | ||
| pN565 | Expression of T7 RNA polymerase mutant | Christopher Voigt et al. [ |
| pACYC− | Expression of SelA and PSTK | Dieter Söll et al. [ |
| pGFIB−tRNAUTuT6 | Expression of tRNAUTuT6 | Jingyan Wei et al. [ |
| pUC57− | pUC57 with | This study |
| pRSF− | Expression of Sec−hGPx3 and its cysteine mutants | This study |
| pRSF− | Expression of hGPx3 (U49S) and its cysteine mutants | This study |
| pRSF− | Expression of short isoform of Sec−shGPx3 and its cysteine mutants | This study |
| pRSF− | Expression of short isoform of shGPx3 (U49S) and its cysteine mutants | This study |
Description of various mutant proteins in this study.
| Protein | Description |
|---|---|
| Sec−hGPx3 | Human GPx3 protein containing Sec49 |
| Sec−hGPx3−C8S | Human GPx3 protein containing Sec49, Ser8 |
| Sec−hGPx3−C8/77S | Human GPx3 protein containing Sec49, Ser8, Ser77 |
| Sec−hGPx3−C8/132S | Human GPx3 protein containing Sec49, Ser8, Ser132 |
| Sec−hGPx3−C77S | Human GPx3 protein containing Sec49, Ser77 |
| Sec−hGPx3−C132S | Human GPx3 protein containing Sec49, Ser132 |
| Sec−hGPx3−C77/132S | Human GPx3 protein containing Sec49, Ser77, Ser132 |
| Sec−hGPx3C8/77/132S | Human GPx3 protein containing Sec49 Ser8, Ser77, Ser132 |
| Sec−shGPx3 | Short isoform of human GPx3 protein containing Sec49 |
| Sec−shGPx3−C77S | Short isoform of human GPx3 protein containing Sec49, Ser77 |
| Sec−shGPx3−C132S | Short isoform of human GPx3 protein containing Sec49, Ser132 |
| Sec−shGPx3−C77/132S | Short isoform of human GPx3 protein containing Sec49, Ser77, Ser132 |
| hGPx3 (U49S)/Ser−hGPx3 | Human GPx3 protein containing Ser49 |
| hGPx3 (U49S)−C8S/Ser−hGPx3−C8S | Human GPx3 protein containing Ser49, Ser8 |
| hGPx3 (U49S)−C8/77S | Human GPx3 protein containing Ser49, Ser8, Ser77 |
| hGPx3 (U49S)−C8/132S | Human GPx3 protein containing Ser49, Ser8, Ser132 |
| hGPx3 (U49S)−C77S | Human GPx3 protein containing Ser49, Ser77 |
| hGPx3 (U49S)−C132S | Human GPx3 protein containing Ser49, Ser132 |
| hGPx3 (U49S)−C77/132S | Human GPx3 protein containing Ser49, Ser77, Ser132 |
| hGPx3 (U49S)−C8/77/132S | Human GPx3 protein containing Ser49, Ser8, Ser77, Ser132 |
| shGPx3 (U49S) | Short isoform of human GPx3 protein containing Ser49 |
| shGPx3 (U49S)−C77S | Short isoform of human GPx3 protein containing Ser49, Ser77 |
| shGPx3 (U49S)−C132S | Short isoform of human GPx3 protein containing Ser49, Ser132 |
| Sec−hGPx3−C8/132U | Human GPx3 protein containing Sec49, Sec8, Sec132 |
Figure 1Expression, purification, and enzymatic activity of Sec−hGPx3; (A) SDS−PAGE analysis of purified Sec−hGPx3 under reducing conditions (Lane 1), reducing conditions without heat−denaturation (Lane 2) and non−reducing conditions without boiling treatment (Lane 3). M, molecular mass markers; (B) Enzymatic activity of Sec−hGPx3 (2.5 μg) was assessed through the decrease of absorbance at 340 nm over time upon the addition of tert−butyl hydroperoxide (t−BuOOH) (60 μM, triangle) or H2O2 (60 μM, upside−down triangle) to a cuvette containing glutathione reductase (GR) (1 U), GSH (1 mM), and NADPH (0.25 mM). Control reactions were spontaneous reduction of H2O2 (circle) and t-BuOOH (squares) without Sec−hGPx3.
Figure 2SDS−PAGE analysis of hGPx3 and hGPx3 mutants under non−reducing conditions without boiling treatment. Lanes are as follows: M: marker; B: blank; 1: Sec−hGPx3; 2: Sec−hGPx3−C8S; 3: Sec−hGPx3−C8/77S; 4: Sec−hGPx3−C8/132S; 5: Sec−hGPx3−C77S; 6: Sec−hGPx3−C132S; 7: Sec−hGPx3−C77/132S; 8: Sec−hGPx3C8/77/132S; 9: Ser−hGPx3; 10: Ser−hGPx3−C8S; 11: Sec−shGPx3; 12: Sec−shGPx3−C77S; 13: Sec−shGPx3−C132S; 14: Sec−shGPx3−C77/132S.
Figure 3SDS−PAGE analysis of hGPx3 (U49S) and hGPx3 (U49S) mutants under reducing conditions with boiling treatment or non−reducing conditions without boiling treatment. Lanes are as follows: 1−1, reduced hGPx3 (U49S); 1−2, non−reduced hGPx3 (U49S); 2−1, reduced hGPx3 (U49S)−C8S; 2−2, non−reduced hGPx3 (U49S)−C8S; 3−1, reduced hGPx3 (U49S)−C8/77S; 3−2, non−reduced hGPx3 (U49S)−C8/77S; 4−1, reduced hGPx3 (U49S)−C8/132S; 4−2, non−reduced hGPx3 (U49S)−C8/132S; 5−1, reduced hGPx3 (U49S)−C77S; 5−2, non−reduced hGPx3 (U49S)−C77S; 6, non−reduced hGPx3 (U49S)−C132S; 7, non−reduced hGPx3 (U49S)−C77/132S; 8, non−reduced hGPx3 (U49S)−C8/77/132S.
Figure 4The overall structure of Sec−hGPx3 with the external N−terminal peptide; Cys8, Cys77, Cys132, and the catalytic center Sec49 are shown as sticks and labeled. The distances were measured and are shown by blue dotted lines and labeled. Cartoon representations were generated in PyMOL.
Figure 5Effect of point mutations on the GPx activity: The GPx activities of WT (Sec−hGPx3) and mutants were analyzed under the same conditions as described in the legend of Figure 1, except 500 μM H2O2 was used. The activity of Sec−shGPx3−C77/132S (56.2 U/mg) was defined as 100%. Student’s t−test was used for statistical analysis. The data are presented as the mean ± SD (n = 3); * p < 0.05, ** p < 0.01.
Figure 6Expression of enzymatically active Sec−hGPx3−C8/132U. (A) SDS−PAGE gel analysis of Sec−hGPx3−C8/132U; Lane 1: reduced Sec−hGPx3−C8/132U; Lane 2: non−reduced Sec−hGPx3−C8/132U; (B) Reduction of t−BuOOH catalyzed by Sec−hGPx3−C8/132U with 10 μM GSH. The reactions were performed with 1 mM EDTA, 0.25 mM NADPH, 0.3 mM t−BuOOH, 1 U GR, and 10 μM GSH, 0.4 μM GPx3 (final concentration) was added to the experimental group.
Figure 7Effects of (A) temperature and (B) PH on the activity of Sec−hGPx3−C8/132U: Activity was determined with the concentrations of GSH and t−BuOOH at 1 mM and 0.3 mM, respectively. (A) Plot of GPx activity versus temperature; the highest activity at 50 °C was set as 100%; (B) Plot of GPx activity versus pH; the highest activity at pH 10 was set as 100%.
Figure 8Double−reciprocal plots for the reduction of t−BuOOH with GSH catalyzed by Sec−hGPx3−C8/132U: (A) Single progression curves at 1.0 mM, 1.5 mM, 3.0 mM, 5.0 mM, and 10.0 mM GSH. (B) The apparent Vmax extrapolated for an infinite concentration of t−BuOOH was plotted against the reciprocal GSH concentrations.